Two of the most studied proton transporters in breast cancer are V-ATPases and NHE1, whose aberrant activity contributes to create a reversed pH gradient that promotes mammary tumor growth and invasiveness [34,35,36]. The gene discussed is SLC9A1; the disease is breast carcinoma.